Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies: A pilot study of treatment with intravenous immunoglobulin

References

• Boey M L, Colaco C B, Gharavi A K, Elkon K B, Loizou S, Hughes G RV. Thrombosis in systemic lupus erythematosus: Striking association with the presence of circulating lupus anticoagulant. Br Med J 1983; 287: 1021–3
   PubMed Web of Science ®Google Scholar
• Harris E N, Gharavi A K, Boey M L. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211–4
   PubMed Web of Science ®Google Scholar
• Mannoussakis M N, Gharavi A K, Drosos A A, Kitridou R C, Moutsopoulos H M. Anticardiolipin antibodies in un-selected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 1987; 44: 297–307
   Google Scholar
• Harris E N, Chan J K, Asherson R A, Aber V R, Gharavi A K, Hughes G RV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153–6
   PubMedGoogle Scholar
• Lockshin M D, Druzin M L, Goei S, Qamar T, Magid M S, Jovanovic L. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313: 152–6
   PubMed Web of Science ®Google Scholar
• Unander A M, Norberg R, Hahn L, Arfors L. Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion. Am J Obstet Gynecol 1987; 156: 114–9
   PubMed Web of Science ®Google Scholar
• Silver R M, Drapner M L, Scott J R, Lyon J L, Reading J, Branch D W. Clinical consequences of antiphospholipid antibodies: A historic cohort study. Obstet Gynecol 1994; 83: 372–7
   Google Scholar
• Matzner W, Chong P, Xu G, Ching W. Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions. J Reprod Med 1994; 39: 27–30
   Google Scholar
• Carreras L O, Vermylen J G. Lupus anticoagulant and thrombosis: Possible role of inhibition of prostaglandin formation. Thromb Haemostas 1982; 48: 28–31
   Google Scholar
• Asherson R A, Harris E N. Anticardiolipin antibodies in the detection of autoimmune disorders. Int Med 1987; 8: 73–80
   Google Scholar
• Lyden T W, Ng A K, Rote N J. Modulation of phosphatidylserine epitope expression on Be Wo cells during forskolin treatment. Am J Reprod Immunol 1992; 27: 24–9
   Google Scholar
• Triplett D A, Harris E N. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol 1989; 21: 123–31
   PubMed Web of Science ®Google Scholar
• Out H J, Bruinse H W, Derksen R HWM. Antiphospholipid antibodies and pregnancy loss. Hum Reprod 1991; 6: 889–97
   PubMedGoogle Scholar
• MacLean M A, Cumming G P, McCall F, Walker I D, Walker J J. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynaecol 1994; 101: 103–6
   PubMedGoogle Scholar
• Branch D W, Scott J R, Kochenour N K, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1322–6
   PubMed Web of Science ®Google Scholar
• Asherson R A, Harris E N. Anticardiolipin antibodies - clinical associations. J Postgrad Med J 1986; 62: 1081–7
   PubMed Web of Science ®Google Scholar
• Scott J R, Rote N S, Branch D W. Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol 1987; 70: 645–6
   PubMedGoogle Scholar
• Cowchock S. Autoantibodies and pregnancy wastage. Am J Reprod Immunol 1991; 26: 38–41
   Google Scholar
• Orvieto R, Achiron A, Ben-Rafael Z, Achiron R. Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies. Fertil Steril 1991; 56: 1013–20
   PubMed Web of Science ®Google Scholar
• Carreras L O, Perez G N, Vega H R, Casavilla F. Lupus anticoagulant and recurrent fetal loss: Successful treatment with gammaglobulin. Lancet 1988; 2: 393–4
   PubMed Web of Science ®Google Scholar
• MacLachlan N A, Letsky E, DeSwiet M, Rodeck C H. The use of intravenous immunoglobulin therapy in the management of anti-phospholipid antibody associated pregnancies. Clin Exp Rheumatol 1990; 8: 221–4
   Google Scholar
• Kaaja R, Julkunen H, Ämmälä P, Palosuo T, Kurki P. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta Obstet Gynecol Scand 1993; 72: 63–6
   PubMed Web of Science ®Google Scholar
• Tan E M, Cohen A S, Fries J F, Masi A T, McShane D J, Rothfield NF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Branch D W, Rote N S, Scott J R. The demonstration of lupus anticoagulant by an enzyme-linked immunoadsorbent assay. Clin Immunol Immunopathol 1986; 39: 298–307
   PubMedGoogle Scholar
• Lopez-Soto A, Casals F J, Font J, Cervera R, Ingelmo M. Detection of antiphospholipid antibodies by an ELISA-method with bovine thromboplastin as antigen. Thromb Res 1989; 53: 623–8
   PubMedGoogle Scholar
• Balasch J, Carmona F, Lopez-Soto A, Font J, Creus M, Fabrgues F. Low-dose aspirin for prevention of pregnancy losses in women with primary anti-phospholipid syndrome. Hum Reprod 1993; 8: 2234–9
   PubMed Web of Science ®Google Scholar
• Vogt E, Lyden T W, Rote N J. Reactivity of human IgM antiphospholipid antibodies against placental trophoblast. Am J Reprod Immunol 1992; 27: 25–9
   Google Scholar
• Reece E A, Gabrielli S, Cullen M T, Zheng X Z, Hobbins J C, Harris E N. Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am J Obstet Gynecol 1990; 163: 162–9
   PubMed Web of Science ®Google Scholar
• Lubbe W F, Butler W S, Palmer S J, Liggins G C. Lupus anticoagulant and pregnancy. Br J Obstet Gynaecol 1984; 91: 357–63
   PubMedGoogle Scholar
• Lockshin M D, Druzin M L, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989; 160: 439–43
   PubMed Web of Science ®Google Scholar
• Wapner R J, Cowchock F S, Shapiro S S. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol 1989; 161: 1271–2
   PubMed Web of Science ®Google Scholar
• Delfraissy J F, Tchernia G, Laurian Y, Dreyfus M, Deryeke M, Mirica C. Suppressor cell function after intravenous gamma globulin treatment in adult chronic idiopathic thrombocytopenic purpura. Br J Haematol 1985; 60: 315–22
   PubMed Web of Science ®Google Scholar
• Nydegger U K. Hypothetic and established action mechanisms of therapy with immunoglobulin G. Immunotherapy with intravenous immunoglobulins, P. Imbach. Academic Press. 1991; 27–36
   Google Scholar
• Kimberly R P, Salmon J E, Bussell J B. Modulation of mononuclear phagocyte function by intravenous gammaglobulin. J Immunol 1987; 132: 745–50
   Google Scholar
• Brand A, Witvliet M, Claas F HJ. Beneficial effect of intravenous gammaglobulin in a patient with complement-mediated autoimmune thrombocytopenia due to IgM-antiplate-let antibodies. Br J Haematol 1988; 69: 507–11
   Google Scholar
• Rossi F, Dietrich G, Kazatchkine M D. Anti-idiotypes against autoantibodies in normal immunoglobulins: Evidence for network regulation of human autoimmune responses. Immunol Rev 1989; 110: 135–42
   PubMed Web of Science ®Google Scholar